IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CCCC

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q4 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Cash & Equivalents78.6161.2774.6058.8178.1651.2955.50126.5959.6529.7549.5557.3046.0076.12162.75281.1594.91
Short-term Investments--------------------264.10250.48245.17233.16239.33184.77218.57
Accounts Receivable1.332.882.406.542.168.033.1011.8010.341.471.491.711.775.724.856.213.66
Total Current Assets262.90245.37258.11206.86224.73232.54257.77271.19273.23287.56325.46318.37302.95325.69412.29477.56322.01
Property, Plant & Equipment4.154.494.745.135.545.485.847.136.217.407.426.343.033.113.323.654.01
Total Non-current Assets*96.5083.49100.9758.6271.8086.9991.84105.26102.83143.28135.98174.11212.54181.0895.6250.8652.00
Total Assets359.40328.86359.08265.49296.53319.52349.60376.45376.06430.84461.44492.48515.49506.77507.91528.42374.01
Accounts Payable1.120.770.861.332.220.681.331.451.501.172.374.453.414.513.754.473.74
Total Current Liabilities48.2527.2533.0335.9544.4640.8245.1842.7743.2944.5545.2746.1546.9951.2548.6944.1737.65
Long-term Debt--------------0.0010.3411.4811.3011.1210.9410.7710.5910.4110.23
Total Non-current Liabilities*63.8967.3669.4675.1478.0183.5688.4487.5790.1197.0697.99101.73103.9765.9160.4467.8372.65
Total Liabilities112.1494.61102.49111.08122.46124.38133.62130.34133.40141.61143.26147.88150.96117.16109.13111.99110.30
Retained Earnings(787.46)(763.82)(738.69)(718.21)(686.04)(660.02)(633.70)(528.38)(599.13)(395.89)(358.70)(326.75)(299.33)(267.71)(252.06)(227.37)(204.79)
Total Stockholder Equity247.27234.25256.59154.41174.06195.14215.99246.11242.66289.23318.18344.59364.53389.61398.78416.43263.71
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Total Revenue6.646.1511.0211.236.467.2415.362.856.7513.837.6520.088.509.78--
Research & Development24.4724.6124.9825.9926.2027.0731.8430.6529.6631.3226.2026.5524.3023.2920.53
Selling, General & Admin8.599.339.188.928.779.3311.7710.509.589.9012.828.788.458.617.41
Total Operating Expenses33.0633.9434.1645.6434.9636.4043.6141.1539.2441.2239.0235.3332.7531.9027.94
Operating Income(26.42)(27.78)(23.14)(34.41)(28.50)(29.16)(28.24)(38.29)(32.49)(27.38)(31.37)(15.25)(24.25)(22.12)(20.51)
Pretax Income----(20.36)(32.17)(26.02)(26.32)(24.67)------(31.62)(15.66)(24.68)(22.58)(20.97)
Tax Provision0.000.000.120.000.000.000.000.000.000.000.00----(0.17)(0.17)
Net Income(23.63)(25.13)(20.49)(32.17)(26.02)(26.32)(24.67)(37.18)(31.96)(27.41)(31.62)(15.66)(24.68)(22.58)(20.97)
Basic EPS(0.18)(0.20)(0.09)(0.44)(0.37)(0.37)(0.35)(0.76)(0.65)(0.56)(0.65)(0.31)(0.51)(0.51)(0.49)
Diluted EPS(0.18)(0.20)(0.09)(0.44)(0.37)(0.37)(0.35)(0.76)(0.65)(0.56)----------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Operating Cash Flow(1.57)(29.94)(22.14)(31.21)(12.06)(33.28)(18.12)(29.13)(28.02)(22.19)(26.60)(25.67)(18.36)(18.00)(24.93)
Capital Expenditures0.040.060.010.410.19--0.001.493.310.530.170.110.000.750.42
Free Cash Flow*(1.61)(30.01)(22.16)(31.62)(12.24)--(18.12)(30.62)(31.32)(22.72)(26.77)(25.78)(18.36)(18.75)(25.35)
Investing Cash Flow(14.81)16.15(80.73)4.0938.9229.13(53.40)9.2819.9133.23(4.00)(59.41)(100.63)32.43(61.73)
Financing Cash Flow33.730.46118.677.770.00(0.05)34.580.050.360.260.480.470.58170.50(0.15)
← Scroll for more columns →

* Derived from reported values